The causal association of the post-translational modification of NuMA with the ability of NuMA to bind proteins [31,87,88,89] could explain the interference of PJ34 with NuMA clustering and binding to HSET in the spindle poles of cancer cells treated with PJ34 [31,80,81,82,83]. This evidence concerns the gene NUMA1 and cancer.